Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(4 sites)
United States
The Angeles Clinic and Research Institute, Los Angeles, California Moffitt Cancer Center, Tampa, Florida University of Chicago Medical Center, Chicago, Illinois Northwell Health Center for Advanced Medicine, New Hyde Park, New York Age range
18 Years and older
Last updated December 2025